CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

Linda Diehl(Leiden University Medical Center), Annemieke Th. den Boer(Leiden University Medical Center), Stephen P. Schoenberger(La Jolla Institute for Immunology), Ellen I. H. van der Voort(Leiden University Medical Center), Ton N. Schumacher(The Netherlands Cancer Institute), Cornelis J.M. Melief(Leiden University Medical Center), Rienk Offringa(Leiden University Medical Center), René E. M. Toes(University of Tübingen)
Nature Medicine
July 1, 1999
Cited by 462

Abstract


Related Papers

No related papers found

Powered by citation graph analysis